首页> 外文期刊>Italian Journal of Anatomy and Embryology >Expression of the endocannabinoid receptors in human fascial tissue
【24h】

Expression of the endocannabinoid receptors in human fascial tissue

机译:内源性大麻素受体在筋膜组织中的表达

获取原文
           

摘要

Endocannabinoids are endogenous lipid mediators with wide range of biological effects similar to those of marijuana. They exert their biological effects via two main G-protein-coupled cannabinoid receptors, the CB1 (cannabinoid receptor 1) and CB2 (cannabinoid receptor 2). Cannabinoid receptors have been localized in the central and peripheral nervous system as well as on cells of the immune system, but recent studies gave evidence for the presence of cannabinoid receptors in different types of tissues (1,2) Their presence was supposed in myofascial tissue, suggesting that the endocannabinoid system may help resolve myofascial trigger points, suppressing proinflammatory cytokines such as IL-1beta e TNF-alpha and increasing anti-inflammatory cytokines (3, 4). However, until now the expression of CB1 and CB2 in fasciae and in fascial fibroblasts has not yet been established. In this work small samples of fascia were collected from volunteers patients: for each sample were done a fibroblast cell isolation, immunohistochemical investigation (CB1 and CB2 antibodies) and real time RT-PCR to detect the expression of CB1 and CB2. The immunostaining results demonstrate the expression of CB2 and CB1 on fascial fibroblasts and fascial tissue. In the tissue not all the fibroblasts are positive, whereas the isolated and expanded cells are homogeneous. These results are confirmed by the real time PCR where the specificity of the reaction on fibroblasts and fascial tissue is the same, but the amount of expression in the tissue is lower, for both CB1 and CB2. This is the first demonstration that the fibroblasts of the muscular fasciae express CB1 and CB2. These results could represent a new target for drugs to care fascial fibrosis and inflammation. The presence of the endocannabinoid system in the fascial fibroblasts can also explain the efficacy of cannabis to care myofascial pain and the possible stimulation during manipulative treatments and exercises (5). More studies about the interactions between fibroblasts, extracellular matrix and CB1 and CB2 receptors could help to understand the role of these receptors on myofascial pain.
机译:内源性大麻素是内源性脂质介质,具有与大麻相似的广泛生物效应。它们通过两个主要的G蛋白偶联大麻素受体CB1(大麻素受体1)和CB2(大麻素受体2)发挥生物学作用。大麻素受体已经定位于中枢神经系统和外周神经系统以及免疫系统的细胞中,但是最近的研究提供了证据表明大麻素受体存在于不同类型的组织中(1,2),据推测它们存在于肌筋膜组织中,表明内源性大麻素系统可能有助于解决肌筋膜触发点,抑制促炎细胞因子,例如IL-1beta eTNF-α和增加抗炎细胞因子(3、4)。但是,到目前为止,尚未确定筋膜和筋膜成纤维细胞中CB1和CB2的表达。在这项工作中,从志愿者患者中收集了少量的筋膜样本:对每个样本进行了成纤维细胞分离,免疫组织化学研究(CB1和CB2抗体)和实时RT-PCR以检测CB1和CB2的表达。免疫染色结果表明CB2和CB1在筋膜成纤维细胞和筋膜组织中表达。在组织中,并非所有的成纤维细胞都是阳性的,而分离和扩增的细胞是均匀的。这些结果通过实时PCR证实,其中对CB1和CB2的反应对成纤维细胞和筋膜组织的特异性相同,但组织中的表达量较低。这是肌肉筋膜成纤维细胞表达CB1和CB2的第一个证明。这些结果可能代表治疗筋膜纤维化和炎症的药物的新目标。筋膜成纤维细胞中存在内源性大麻素系统也可以解释大麻治疗肌筋膜疼痛的功效以及在手法治疗和锻炼过程中可能的刺激作用(5)。关于成纤维细胞,细胞外基质与CB1和CB2受体之间相互作用的更多研究可能有助于了解这些受体在肌筋膜疼痛中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号